Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

Activation of the sigma receptor is a block box. Ifenprodil activating this receptor might have huge therapeutic potential. Needs more research. What we are finding out quickly is the interconnection between neurological system, endocrine (hormones...) system, and inflammatory system. Blocking NMDA receptors likely has impact on decreasing local/circulating immune cells in the lungs, reducing hyperexcitable neurological response that is damaging, and also blocking leaky microvasculature so less acute lung INJURY and ARDS